Tenet Healthcare Corporation New (THC) is a publicly traded Healthcare sector company. As of October 3, 2026, THC trades at $256.99 with a market cap of $20.45B and a P/E ratio of 16.53. THC moved +1.83% today. Year to date, THC is +29.67%; over the trailing twelve months it is +27.16%. Its 52-week range spans $109.82 to $283.05. Analyst consensus is strong buy with an average price target of $283.31. Rallies surfaces THC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for THC, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $256.99 |
| Market Cap | $20.45B |
| P/E Ratio | 16.53 |
| EPS | $15.61 |
| Dividend Yield | 0.00% |
| 52-Week High | $283.05 |
| 52-Week Low | $109.82 |
| Volume | 385.86K |
| Avg Volume | 0 |
| Revenue (TTM) | $21.31B |
| Net Income | $2.37B |
| Gross Margin | 0.00% |
17 analysts cover THC: 0 strong buy, 15 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $283.31.